Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/23096| Title: | 'Classical' but not 'other' mutations of EGFR kinase domain are associated with clinical outcome in gefitinib-treated patients with non-small cell lung cancer |
| Institution and School/Department of submitter: | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής |
| Keywords: | Adult,Aged,Aged, 80 and over,Antineoplastic Agents/therapeutic use,Binding Sites/genetics,Carcinoma, Non-Small-Cell Lung/*drug therapy/genetics/pathology,DNA Mutational Analysis,Disease Progression,Female,Gene Frequency,Genotype,Humans,Kaplan-Meier Estimate,Lung Neoplasms/*drug therapy/genetics/pathology,Male,Middle Aged,*Mutation,Prognosis,Protein Kinase Inhibitors/therapeutic use,Quinazolines/*therapeutic use,Receptor, Epidermal Growth Factor/*genetics,Time Factors,Treatment Outcome |
| URI: | https://olympias.lib.uoi.gr/jspui/handle/123456789/23096 |
| ISSN: | 0007-0920 |
| Link: | http://www.ncbi.nlm.nih.gov/pubmed/18000506 http://www.nature.com/bjc/journal/v97/n11/pdf/6604068a.pdf |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Pallis-2007-'Classical' but not.pdf | 147.32 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License
